Literature DB >> 7059870

Juvenile dermatomyositis: medical, social and economic status in adulthood.

A Chalmers, R Sayson, K Walters.   

Abstract

Eighteen adults were studied an average of 18.5 years after the diagnosis of juvenile dermatomyositis had been made. Persistent weakness was found in six patients and recurrent rash in the classic distribution in seven. Other clinical features present were Raynaud's phenomenon, arthritis and subcutaneous nodules. Minor increases in the serum creatine phosphokinase level were noted in seven patients and did not correlate with the presence of weakness or rash. Educational achievement and employment status were better in this group than in a group of adults with juvenile rheumatoid arthritis or the general adult population of British Columbia. Significant residual disability related to calcinosis and flexion contractures was present in only three of the patients.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7059870      PMCID: PMC1862806     

Source DB:  PubMed          Journal:  Can Med Assoc J        ISSN: 0008-4409            Impact factor:   8.262


  9 in total

Review 1.  DERMATOMYOSITIS.

Authors:  S BITNUM; C W DAESCHNER; L B TRAVIS; W F DODGE; H C HOPPS
Journal:  J Pediatr       Date:  1964-01       Impact factor: 4.406

2.  DERMATOMYOSITIS AND FOCAL SCLERODERMA.

Authors:  C D COOK; F S ROSEN; B Q BANKER
Journal:  Pediatr Clin North Am       Date:  1963-11       Impact factor: 3.278

3.  Late progression in dermatomyositis in childhood.

Authors:  J J Miller
Journal:  J Pediatr       Date:  1973-10       Impact factor: 4.406

4.  Childhood polymyositis. A follow-up study with special reference to treatment with corticosteroids.

Authors:  A L Rose
Journal:  Am J Dis Child       Date:  1974-04

5.  Prognosis in childhood dermatomyositis.

Authors:  D B Sullivan; J T Cassidy; R E Petty; A Burt
Journal:  J Pediatr       Date:  1972-04       Impact factor: 4.406

6.  Factors affecting survivorship in polymyositis. A life-table study of 124 patients.

Authors:  T A Medsger; H Robinson; A T Masi
Journal:  Arthritis Rheum       Date:  1971 Mar-Apr

7.  Juvenile rheumatoid arthritis: follow-up into adulthood - medical, sexual and social status.

Authors:  R H Hill; A Herstein; K Walters
Journal:  Can Med Assoc J       Date:  1976-05-08       Impact factor: 8.262

8.  Juvenile dermatomyositis.

Authors:  R H Hill; W S Wood
Journal:  Can Med Assoc J       Date:  1970-11-21       Impact factor: 8.262

9.  Juvenile dermatomyositis: a clinical and immunologic study.

Authors:  L M Pachman; N Cooke
Journal:  J Pediatr       Date:  1980-02       Impact factor: 4.406

  9 in total
  3 in total

Review 1.  Long-term outcomes in juvenile dermatomyositis: how did we get here and where are we going?

Authors:  Adam Huber; Brian M Feldman
Journal:  Curr Rheumatol Rep       Date:  2005-12       Impact factor: 4.592

2.  Drug treatment of juvenile dermatomyositis.

Authors:  G Miller; J Z Heckmatt; V Dubowitz
Journal:  Arch Dis Child       Date:  1983-06       Impact factor: 3.791

3.  Mortality in children with juvenile dermatomyositis: two decades of experience from a single tertiary care centre in North India.

Authors:  Surjit Singh; Deepti Suri; Roosy Aulakh; Anju Gupta; Amit Rawat; Rohit Manoj Kumar
Journal:  Clin Rheumatol       Date:  2014-07-23       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.